Previous close | 0.0300 |
Open | 0.0500 |
Bid | 0.0000 |
Ask | 0.2300 |
Strike | 27.00 |
Expiry date | 2025-01-17 |
Day's range | 0.0300 - 0.0500 |
Contract range | N/A |
Volume | |
Open interest | 2.67k |
Peloton isn't profitable as a subscription business, but it looks different as a media company.
Amgen is the latest biotech to benefit from obesity drug optimism, Sony and Apollo offer Paramount Global $26 billion cash in takeover move, and other news to start your day.
Amidst leadership transitions and market adjustments, Peloton reports a significant quarter with strategic restructuring and a focus on sustainable growth.